<DOC>
	<DOCNO>NCT01819870</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic characteristic safety dilatrend SR capsule 32mg Dilatrend tablet 25mg healthy male subject .</brief_summary>
	<brief_title>Study Compare Pharmacokinetic Characteristics Safety Dilatrend SR Capsule 32mg Dilatrend Tablet 25mg</brief_title>
	<detailed_description>Healthy male subject administrate multiple-dose period I II ( Crossover ) dilatrend SR capsule 32mg dilatrend tablet 25mg .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Between 20 age 35aged healthy male Body Weight 50kg , within 20 % ideal body weight ( IBW ) . IBW ( kg ) = { height ( cm ) 100 } *0.9 Have congenital chronic disease medical symptom . Suitable result inspection ( laboratory test , ECG , etc ) within 21 day IP administration . Agreement write informed consent Subject hypersensitivity reaction clinically significant history carvedilol investigator drug . Clinically significant cardiovascular system , respiratory system , liver , kidney , endocrine system , gastrointestinal system , central nervous system , blood tumor , mental disease , skin disease , otorhinolaryngologic disease . Hypotension ( SBP &lt; 105mmHg DBP &lt; 65mmHg ) , Hypertension ( SBP &gt; 150mmHg DBP &gt; 100mmHg ) Heart rate &lt; 50times/minute Active liver disease AST , ALT &gt; 1.5*upper limit normal range Creatinine clearance &lt; 80mL/min Subject disease affect drug 's ADME gastrointestinal surgery . Subject symptom injure acute disease within 28days first IP administration . Subject history drug abuse positive reaction drug abuse screen test urine . Taking ETC medicine include oriental medicine within 14days first IP administration Taking OTC medicine within 7days Subject take abnormal meal affect ADME drug . Previously participate trial within 90days . Previously make whole blood donation within 60days component blood donation within 30days first IP administration . Continued take caffeine ( caffeine &gt; 5cup/day ) , drink ( alcohol &gt; 21unit/week , 1unit = 10g = 12.5mL pure alcohol ) clinical trial drink severe heavy smoker ( cigarette &gt; 10cigarettes/day ) . Subject positive reaction serum test ( HBsAg , HCV Ab , HIV Ag/Ab , VDRL ) Genetic problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption . An impossible one participate clinical trial investigator 's decision include reason laboratory test result .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Carvedilol</keyword>
	<keyword>Dilatrend SR capsule</keyword>
	<keyword>Dilatrend Tablet</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy male subject</keyword>
</DOC>